Treatment of gonorrhoea with trimethoprim-sulphamethoxazole and probenecid plus procaine penicillin in Rwanda.

A. Meheus,E. Ngamije,P. Freyens
DOI: https://doi.org/10.1136/STI.50.6.447
1974-12-01
Abstract:Since its introduction in 1967, many authors in industrialized countries have reported excellent results in the treatment of gonorrhoea with a combination of trimethoprim and sulphamethoxazole (Csonka and Knight, 1967; Schofield, Moffett, Masterton, and McGill, 1969; Carroll and Nicol, 1970; Ullmann, Niordson, and Zachariae, 1971; Siboulet, 1971; Rodin and Seth, 1972; van Dijk and Tan Lim, 1973). Unsatisfactory results were reported by Wright and Grimble (1970), and an intermediate result by Evans, Churcher, and Hluman (1972). For developing countries, with their overwhelming demand for gonorrhoea treatment, few therapeutic studies are available. Arya, Pearson, Rao, and Blowers (1970) reported an unsatisfactory cure rate with low doses of trimethoprim-sulphamethoxazole (T-SM) but a high cure rate with higher doses. Kloosman (1972) reported excellent results with three different single-dose schedules of T-SM in South Africa. Arya and Bosa (1973) evaluated the efficacy of different penicillin schedules in Uganda. The aim of this study is to evaluate the efficacy (a) of our standard gonorrhoea treatment in Rwanda: probenecid 1 g. by mouth followed after 1 hr by 4-8 m.u. procaine penicillin intramuscularly and (b) of trimethoprim-sulphamethoxazole* in two different treatment schedules: a single dose of eight tablets, and a dosage of twenty tablets spread over 4 days.
What problem does this paper attempt to address?